MedTrace Logo

The Gut Microbiota in Obsessive-Compulsive Disorder

NCT02285699 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 43

Last updated 2020-09-02

No results posted yet for this study

Summary

This study will examine the gut microbiota and serum inflammatory markers in patients with Obsessive-Compulsive Disorder vs. healthy controls. Phase II of the study will examine the gut microbiota and cytokine levels following 12-weeks of treatment with Selective Serotonin Reuptake Inhibitors (SSRIs).

Conditions

  • Obsessive-Compulsive Disorder

Interventions

DRUG

SSRIs

12-weeks of standard SSRi treatment for those interested in Phase II of the study.

Sponsors & Collaborators

Principal Investigators

  • Michael Van Ameringen, MD, FRCPC · McMaster University

Study Design

Allocation
NA
Purpose
OTHER
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2014-11-01
Primary Completion
2016-03-01
Completion
2016-03-01

Countries

  • Canada

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02285699 on ClinicalTrials.gov